Why Our SPF Isn't Launching Until Spring 2027

May 08, 2026 4 min read

TL;DR

Our SPF is delayed by a year because it wasn't testing at the right SPF level (which is an industry-wide issue currently in the spotlight).

I refuse to cut corners by manipulating results or rushing to market, so it's coming out next year with two new features:

  • a tinted formula that blends better on a wide range of skin tones
  • two sizes: a mini and a family size
I'm here with some less-than-ideal news that does indeed have a silver lining.

The SPF won't be ready to launch this year. Here's what happened...

Before moving on to FDA required in vivo testing (AKA on human test subjects), my manufacturer followed best practices and did an in vitro (AKA in a petri dish) test that simulates human skin's reaction to UV exposure.

The resulting SPF was nowhere near our goal of 30.

Then I came to learn something really surprising from my manufacturer: sunscreens are having a really big problem with performance vs. label claims right now.

What's happening with SPF in general?

There is a growing scandal in the sunscreen industry that most brands don't want you to know about.

It's a systemic problem with how SPF is tested, reported, and labeled vs. how they actually perform.

BeautyMatter, an industry trade publication, recently contacted 36 of the top-selling sunscreen brands at Sephora, Ulta, CVS, Target, and Credo, and asked them to simply hand over their SPF test reports.

30 out of 36 refused, ignored the request, or sent incomplete data. Only 2 of 36 brands (Beauty of Joseon and Badger) submitted fully valid results.

That's a 94% failure rate among household names you probably have in your bathroom cabinet right now.

Why you should care

Here's the thing most people don't know about SPF numbers: there is no objectively "true" SPF.

Every result—and therefore every label claim—is an estimated average—and that average is produced by a surprisingly human, surprisingly subjective process.

Under FDA rules, SPF is tested on live human subjects, called "in vivo" testing.

A technician applies sunscreen to 10 people's backs, shines UV light on them, and then another technician visually judges when their skin starts to redden.

It's a human applying, a human evaluating, and the result is an average across 10 people who all have different skin.

Dr. Curtis Cole, a leading expert who has helped develop global SPF testing standards since 2007, published research showing that even the best, most rigorously audited labs produce in vivo results with ±64% variability.

That means a product that tests as an SPF 50 at one lab could legitimately test as an SPF 18 at another.

And before testing even begins, brands submit a "target number" to the lab—the SPF they want to hit.

If the lab doesn't deliver that number, brands shop for a lab that will.

Experts interviewed by BeautyMatter confirmed that labs have lost years of business for telling clients the truth. The financial pressure to produce a favorable result is enormous.

The manipulation shows up in the data.

Legitimate SPF results, across 10 human subjects, should be messy with variable results across multiple individuals.

Research based on 9,400 test subjects shows that only 0.6% of people naturally land on the same result.

But some reports BeautyMatter reviewed showed 80% identical results. That's a clear sign of cherry picking and data manipulation.

The legal system is starting to catch up: Clinique, L'Oréal's La Roche-Posay, and Sun Bum are all currently facing class-action lawsuits for SPF label claims that independent testing found to be significantly overstated.

Best practice vs. what most brands do

Before submitting our SolScreen for in vivo testing, our lab did 3 rounds of vitro testing, in which a robot applies samples to plates that mimic human skin.

SPF is then calculated through optical instrumentation vs. visual grading by a human.

Here's the kicker: most brands don't do in vitro testing, because it's not required by the FDA.

But we don't play that game. We will do this the right way, or not at all.

So when three labs came back with an SPF 5, we were devastated, but there was zero question in my mind what we were going to do next.

Why (+ how) we're going back to the drawing board

We knew going into SolScreen that SPF was the most regulated, most complex, most litigious product category in beauty. We take that seriously.

Rather than rush or cut corners to make a 2026 launch a reality, we are going to take the extra year to make an SPF that:
  1. Actually has an SPF value that lives up to its label claim
  2. Performs better than other mineral options on a wider range of skin tones
  3. Comes in two sizes: one TSA-friendly, one family-friendly
We're in the process of reformulating with two, non-nano molecule sizes of zinc to raise the SPF level.

We're also adding in a tint so it blends seamlessly on an even wider range of skin tones.

And we're going to do in vitro testing before we get to the required in vivo.
 

Trust > Timing

I have built Bright Body from the ground up based on one key thing: trust.

You all have trusted me to make safe, high-performing products.

And sunscreen is NO exception.

In fact, this product is WAY more serious than a shampoo. We are talking about preventing skin cancer here.

I have zero intention of fudging results to meet a timeline.

I am unequivocally committed to making the best possible product with a manufacturing partner who feels the same.

SolScreen will be worth the wait. And when it launches, you'll know the number on the label is real.


Leave a comment

Comments will be approved before showing up.